Rafael Holdings IncNYSE RFL Stock Report

Rafael Holdings, Inc. owns interest in commercial real estate assets and clinical stage pharmaceutical companies. The company is headquartered in Newark, New Jersey and currently employs 22 full-time employees. The company went IPO on 2018-03-12. The firm owns interests in clinical and early-stage pharmaceutical companies and commercial real estate assets. The firm is focused on the discovery of cancer and immune metabolism therapeutics. The firm operates through two segments: Pharmaceuticals and Real Estate. The Pharmaceuticals segment is comprised of preferred and common equity interests and the Warrant to purchase equity interests in Rafael Pharmaceuticals, a majority equity interest in LipoMedix, Barer, Levco, Farber and Rafael Medical Devices. The Real Estate segment consists of the Company's real estate holdings associated with a portion of an office building in Israel.